Skip to main content

Table 1 Overall survival analysis results of differentially expressed genes in early-stage basal-like/triple-negative breast cancer

From: Screening potential immune signatures for early-stage basal-like/triple-negative breast cancer

Genes

P value

HR

Low 95% CI

High 95% CI

TROAP

0.025391

11.58053

1.352293

99.17133

CLDN7

0.028033

10.57329

1.289517

86.69483

GAS2L3

0.030351

10.3481

1.248294

85.78358

GAL

0.030437

10.5947

1.249694

89.82009

ZYG11A

0.03095

10.42861

1.239709

87.72707

UCK2

0.033021

10.17053

1.205618

85.79805

ANLN

0.033041

9.89309

1.20264

81.38202

PLPP1

0.034681

0.10048

0.011913

0.847494

PGAM5

0.036512

9.426576

1.151162

77.19189

GRHL2

0.038303

9.417034

1.128453

78.58594

FAM83D

0.038744

9.148677

1.121338

74.64144

HYLS1

0.039237

9.069905

1.114938

73.78271

SLC7A5

0.039748

9.121387

1.109184

75.00985

IL33

0.041652

0.112615

0.013774

0.920752

CENPE

0.042031

8.895662

1.081924

73.14081

YWHAZ

0.043559

8.711763

1.064576

71.29114

COA7

0.044402

8.712899

1.055671

71.91126

LIFR

0.04678

0.118868

0.014565

0.970122

ESPL1

0.047336

8.37144

1.025295

68.35204

PARPBP

0.048269

8.307202

1.016239

67.90686

TTC36

0.048538

0.120893

0.014815

0.986523

DOCK6

0.049538

8.280691

1.004277

68.27783

  1. HR hazard ratio, CI confidence interval, BC breast cancer